Paul Senn was Vice-President, Business Development at Sensile Medical (now part of Gerresheimer) from January 2017. Prior to Sensile, Dr Senn held several management positions with increasing responsibilities in pharmaceutical and medical device companies in business development, marketing and development of drug products and design of medical devices. He holds a Master’s degree in Chemistry and a PhD in Physical Chemistry from the University of Basel (Switzerland) and received a management education at the International Institute for Management Development (Lausanne, Switzerland).